Medicare Part B (Hospital Outpatient) Market Analysis

Breast Lesion Localization Methods Market to Reach USD 1.42B by 2033 at 8.3% CAGR

Medicare reimburses breast localization under the OPPS APC system, which bundles device costs into the surgical episode. CMS has not established a separate pass-through payment category for most wire-free localization devices, constraining the net economics for facilities serving Medicare-heavy patient populations. U.S. health spend at 16.69% of GDP (wb:USA-SH.XPD.CHEX.GD.ZS-2023) reflects the scale of the CMS budget pressure context.